Could cause temporary or reversible harm; serious harm is unlikely.
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
| Brand name | DESMOPRESSIN ACETATE |
| Generic name | DESMOPRESSIN ACETATE |
| Active ingredient(s) | DESMOPRESSIN ACETATE |
| Distributed by / for | Apotex Corp. |
| NDC | 60505-0815-0 |
| Full product label | Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0 |
| Recalling firm | Apotex Corp. |
| Distribution | U.S.A. Nationwide |
| Quantity | N/A |
| Recall initiated | 2026-04-08 |
| Report date | 2026-04-22 |
| Recall completed | — |
| Recall number | D-0510-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Weston FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗